Eledon Pharmaceuticals To Present Updated Data From Ongoing Phase 1B Trial Of Tegoprubart In Patients Undergoing Kidney Transplantation At The American Transplant Congress

Press/Media

Period9 May 2024

Media coverage

1

Media coverage

  • TitleEledon Pharmaceuticals To Present Updated Data From Ongoing Phase 1B Trial Of Tegoprubart In Patients Undergoing Kidney Transplantation At The American Transplant Congress
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date9/05/24
    PersonsAllan Kirk